Filing Details
- Accession Number:
- 0001354488-14-001654
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-02 17:24:59
- Reporting Period:
- 2014-04-01
- Filing Date:
- 2014-04-02
- Accepted Time:
- 2014-04-02 17:24:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1024126 | Pernix Therapeutics Holdings Inc. | PTX | Pharmaceutical Preparations (2834) | 330724736 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1485508 | C. Cooper Collins | 33219 Forest West Dr Magnolia TX 77354 | Chief Strategic Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-04-01 | 66,102 | $5.28 | 2,523,944 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-04-02 | 23,898 | $5.19 | 2,500,046 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 245,163 | Indirect | Spouse |
| Common Stock | 390,681 | Indirect | GRAT |
| Common Stock | 390,681 | Indirect | Spousal GRAT |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/26/13.
- The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.16 to $5.40, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.09 to $5.27, inclusive. The reporting person undertakes to provide to Pernix Therapeutics Holdings, Inc., any security holder of Pernix Therapeutics Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
